Influenza A Virus

6 registered clinical trials studyying Influenza A Virus.

Status	Trial	Sponsor	Phase
Withdrawn	Novel Assays for Detection of Influenza Virus NCT03924284	The University of Hong Kong	—
Completed	A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With O NCT02532283	Janssen Research & Development, LLC	Phase 2
Completed	A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations NCT02659735	Janssen Research & Development, LLC	Phase 1
Terminated	Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU NCT01010087	University of Manitoba	Phase 2
Completed	Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus NCT00489931	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	Safety Study of Avian Flu Vaccine NCT00408109	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1